Further, MAPK/ERK signaling was also activated during this progress, implying that HMGB3 and MAPK/ERK have important roles in modulating stem-like properties of ovarian cancer cells (Fig. 5B and C). Here, HMGB3 is linked to ovarian carcinoma.